The Lobbying Register, read carefully Epicycle

Returns

Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.

Clear all

Showing returns filed by Roche .

Filed returns
33
match these filters
Matching filed returns per period 0 2 5 7 10 Jan–Apr 2017: 1 filed returns May–Aug 2017: 1 filed returns Sep–Dec 2017: 1 filed returns Jan–Apr 2018: 2 filed returns May–Aug 2018: 7 filed returns Sep–Dec 2018: 6 filed returns Sep–Dec 2021: 1 filed returns Jan–Apr 2022: 1 filed returns Sep–Dec 2022: 1 filed returns Sep–Dec 2024: 4 filed returns May–Aug 2025: 2 filed returns Sep–Dec 2025: 1 filed returns May–Aug 2026: 5 filed returns 2017 2018 2022
Filed returns per four-month period Click a column to list its returns.
PeriodRegistrantPolicy areaSubject, as filedOfficials namedLink
May–Aug 2026 Roche Health Reframing state expenditure on innovative pharmaceuticals as a macroeconomic investment within national health and enterprise policy. (Public policy or programme) 4 On lobbying.ie
May–Aug 2026 Roche Health Revisions to the EU Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR) legislative frameworks in the context of Ireland’s H2 2026 Presidency of the Council of the European Union. (Legislation) 5 On lobbying.ie
May–Aug 2026 Roche Economic Development and Industry Progression and refinement of legislative proposals within the EU Biotech Act during Ireland’s H2 2026 Presidency of the Council of the European Union. (Public policy or programme) 5 On lobbying.ie
May–Aug 2026 Roche Economic Development and Industry Integration of established national health and clinical research implementation frameworks into Ireland’s National Life Science Strategy (Public policy or programme) 5 On lobbying.ie
May–Aug 2026 Roche Economic Development and Industry Quantitative target-setting and governance structures for Ireland’s National Life Science Strategy. (Public policy or programme) 9 On lobbying.ie
Sep–Dec 2025 Roche Health The development of a National Life Science Strategy should embrace international best practices through a coordinated, cross-departmental approach (Public policy or programme) 1 On lobbying.ie
May–Aug 2025 Roche Economic Development and Industry The development of a National Life Science Strategy should embrace international best practices through a coordinated, cross-departmental approach (Public policy or programme) 6 On lobbying.ie
May–Aug 2025 Roche Health Reform of national pricing and reimbursement systems for new medicines and sustainable increased investment in innovative medicines (Public policy or programme) 6 On lobbying.ie
Sep–Dec 2024 Roche Health Patient access to new medicines (Public policy or programme) 4 On lobbying.ie
Sep–Dec 2024 Roche Economic Development and Industry National Life Science Strategy (Public policy or programme) 1 On lobbying.ie
Sep–Dec 2024 Roche Health Patient access to new medicines (Public policy or programme) 1 On lobbying.ie
Sep–Dec 2024 Roche EU Affairs Urban Waste Water Treatment Directive (Legislation) 1 On lobbying.ie
Sep–Dec 2022 Roche Health Access to orphan medicinal products (Public policy or programme) 1 On lobbying.ie
Jan–Apr 2022 Roche Health Access to medicines and health data infrastructure (Public policy or programme) 1 On lobbying.ie
Sep–Dec 2021 Roche Health Request to consider issuing a temporary authorisation of a medicinal product (Public policy or programme) 1 On lobbying.ie
Sep–Dec 2018 Roche Health drug reimbursement (Public policy or programme) 1 On lobbying.ie
Sep–Dec 2018 Roche Health drug reimbursement (Public policy or programme) 3 On lobbying.ie
Sep–Dec 2018 Roche Health drug reimbursement (Public policy or programme) 2 On lobbying.ie
Sep–Dec 2018 Roche Health drug reimbursement (Public policy or programme) 1 On lobbying.ie
Sep–Dec 2018 Roche Health drug reimbursement (Public policy or programme) 1 On lobbying.ie
Sep–Dec 2018 Roche Health drug reimbursement (Public policy or programme) 1 On lobbying.ie
May–Aug 2018 Roche Health drug reimbursement (Public policy or programme) 2 On lobbying.ie
May–Aug 2018 Roche Health drug reimbursement (Public policy or programme) 2 On lobbying.ie
May–Aug 2018 Roche Health drug reimbursement (Public policy or programme) 1 On lobbying.ie
May–Aug 2018 Roche Health drug reimbursement (Public policy or programme) 1 On lobbying.ie
May–Aug 2018 Roche Health drug reimbursement (Public policy or programme) 1 On lobbying.ie
May–Aug 2018 Roche Health drug reimbursement (Public policy or programme) 2 On lobbying.ie
May–Aug 2018 Roche Health drug reimbursement (Public policy or programme) 1 On lobbying.ie
Jan–Apr 2018 Roche Health Reimbursement of new drugs (Matters involving public funds) 5 On lobbying.ie
Jan–Apr 2018 Roche Health Reimbursement of new drugs (Matters involving public funds) 1 On lobbying.ie
Sep–Dec 2017 Roche Health Drug Reimbursement (Public policy or programme) 24 On lobbying.ie
May–Aug 2017 Roche Health Drug Reimbursement (Public policy or programme) 6 On lobbying.ie
Jan–Apr 2017 Roche Health Drug Reimbursement (Public policy or programme) 1 On lobbying.ie

Policy areas in these returns

Public policy areaFiled returnsShareRelative to the largest
Health 27 81.8%
Economic Development and Industry 5 15.2%
EU Affairs 1 3.0%